Snowball logo
logo
3012

Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A

301246 SHE
¥21.24+¥0.06  (0.28%)
Estimate
P/E
33.2
EPS
0.64
Beta
0.888
Growth
Revenue, YoY
62.31%
Net income, YoY
1,524.43%
FCF, YoY
-275.61%
Dividends
Dividend yield
0.24%
Annual payout
¥0.05
Next ex. div date
June 26, 27
Payout
23.58%
Dividend growth streak
1 year
Div.rating
About the company
Ticker
301246
ISIN
CNE100005ZB9
Country
China
Sector (GICS)
Healthcare
Hubei Hongyuan Pharmaceutical Technology Co., Ltd., together with its subsidiaries, produces and sells pharmaceutical products in China and internationally. The company offers active pharmaceutical ingredients, such as metronidazole, benzoyl metronidazole, dimetrizole, and acyclovir; pharmaceutical intermediates, including imidazole, glyoxylic acid, 2-methyl imidazole, 2-methyl-5-nitroimidazole, sulfate, guanine, diacetyl guanine, and diacetylacyclovir; organic chemical raw materials comprising glyoxal, and oxalic acid; and new energy materials consisting of lithium hexafluorophosphate. It also is involved in the production and sales of triamines, guanine and other products; research and development, production, and sales of pharmaceutical preparations; trading of APIS, pharmaceutical intermediates, organic chemical raw materials, etc.; fluoride salts and other fluorine-containing chemical products; and pharmaceutical wholesale, retail, etc. Hubei Hongyuan Pharmaceutical Technology Co., Ltd. was founded in 2002 and is headquartered in Huanggang, China.

Frequently asked questions

What sector does Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246) operate in?

Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246) current stock price?

As of the latest data, Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A stock price is CN¥21.24, with a previous close of CN¥21.18. Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A gained CN¥0.06 in the last trading session, representing a 0.28% increase.

What is Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246) current market capitalization?

Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A market cap is approximately 8.50 billion.

What is Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.64.

What is Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246) Price-to-Earnings (P/E) ratio?

Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A current P/E ratio is 33.19.

Does Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246) pay dividends?

Yes. Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A pays annual dividends with an annualized yield of 0.24% and an estimated annual payout of CN¥0.05 per share.

When is the next ex-dividend date for Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246)?

The next ex-dividend date is scheduled for June 26, 2027.

What is Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246) beta (volatility) score?

Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A has a beta of 0.888, meaning its volatility is roughly in line with the market.